Walleye Trading LLC Aurinia Pharmaceuticals Inc. Put Options Transaction History

Walleye Trading LLC

11 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2024 May 15, 2024	BUY	$4.93 - $9.31 $986 - $1,862	200 Added 200.0%	300 $1,000
Q4 2023 Feb 14, 2024	SELL	$7.13 - $9.49 $1,426 - $1,898	-200 Reduced 66.67%	100 $0
Q3 2023 Nov 14, 2023	BUY	$7.77 - $12.27 $2,331 - $3,681	300 New	300 $2,000
Q1 2023 May 15, 2023	BUY	$5.94 - $11.27 $4,752 - $9,016	800 New	800 $8,000
Q3 2022 Nov 14, 2022	BUY	$6.66 - $12.39 $8,658 - $16,107	1,300 New	1,300 $10,000
Q1 2022 May 16, 2022	SELL	$10.05 - $22.48 $79,395 - $177,592	-7,900 Reduced 88.76%	1,000 $12,000
Q3 2021 Nov 15, 2021	BUY	$10.93 - $23.55 $44,813 - $96,555	4,100 Added 85.42%	8,900 $197,000
Q2 2021 Aug 16, 2021	BUY	$10.0 - $14.52 $28,000 - $40,656	2,800 Added 140.0%	4,800 $62,000
Q1 2021 May 17, 2021	SELL	$12.3 - $18.73 $119,310 - $181,681	-9,700 Reduced 82.91%	2,000 $26,000
Q4 2019 Feb 14, 2020	BUY	$3.88 - $21.42 $6,596 - $36,414	1,700 Added 17.0%	11,700 $237,000
Q3 2019 Nov 14, 2019	BUY	$5.34 - $6.59 $53,400 - $65,900	10,000 New	10,000 $53,000

209

58.7M

1.14M

1.51M

Ticker AUPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,892,000
Market Cap $1.15B
Description
Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Trading LLC with notifications on news.